Page last updated: 2024-12-07

2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone: metabolite of butylated hydroxytoluene; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107736
SCHEMBL ID1252912
MeSH IDM0083219

Synonyms (22)

Synonym
AKOS015841124
2,6-di-t-butyl-4-methylene-2,5-cyclohexadiene-1-one
2607-52-5
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone
bht-qm
2,6-bis(1,1-dimethylethyl)-4-methylene-2,5-cyclohexadien-1-one
bht-quinone methide
2,6-di-t-butyl-4-methylene-2,5-cyclohexadienone
2,6-ditert-butyl-4-methylidenecyclohexa-2,5-dien-1-one
unii-49860vi52b
2,5-ccyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-methylene-
49860vi52b ,
2,5-ccyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4- methylene-
2,6-bis(1,1-dimethylethyl)-4-methylene-2,5-cyclohexadien-1- one
SCHEMBL1252912
JJQCWPWUHZFKBN-UHFFFAOYSA-N
DTXSID70180707
2,6-ditert-butyl-4-methylene-cyclohexa-2,5-dien-1-one
2,5-cyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-methylene-
2,6-di-tert-butyl-4-methylenecyclohexa-2,5-dienone
Q27259250
2,6-di-tert-butyl-4-methylidenecyclohexa-2,5-dien-1-one

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"-butyl-4-[alpha, alpha, alpha-2H3]methylphenol (BHT-d3) showed a significantly lower toxic potency of the latter."( Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl group.
Mizutani, T; Tajima, K; Yamamoto, K, 1983
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Volumes and weights of stomachs and contents, and volumes of gastric contents of rats given 800 mg/kg BHT, were 2-3 times larger than those of controls 4-7 h after dosing while there were no significant differences at 24-27 h after dosing."( Gastric retention and delayed absorption of a large dose of butylated hydroxytoluene in the rat.
Takahashi, O, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (64.29)18.7374
1990's3 (21.43)18.2507
2000's2 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]